As neoantigen therapies continue to evolve, collaboration across the industry is critical. Progress is being driven not just by individual breakthroughs, but by shared learning across companies.
The 9th International Neoantigen Summit brings together the organisations shaping the future of the field.
Who You'll Meet
Attendees include a growing network of biotech and pharma companies working across discovery, translational, and clinical development, including:
Why This Matters
This isn’t just a speaker line-up, it’s a room full of peers actively tackling the same scientific and clinical challenges.
With structured networking built into the agenda, you can:
- Exchange insights with teams at similar stages
- Build partnerships to accelerate development
- Learn directly from companies delivering clinical progress
A Highly Targeted Networking Environment
Because the event is focused exclusively on neoantigen therapies, the audience is uniquely specialised.
That means better conversations, more relevant introductions, and stronger long-term connections.
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions